tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Hutchmed announces NDA acceptance in China, payment from AstraZeneca
The FlyHutchmed announces NDA acceptance in China, payment from AstraZeneca
10h ago
AZN
HCM
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
PremiumClass Action
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
6d ago
AZN
Achilles Therapeutics sells technology assets to AstraZeneca for $12M
PremiumThe Fly
Achilles Therapeutics sells technology assets to AstraZeneca for $12M
9d ago
AZN
ACHL
AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU
PremiumThe Fly
AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU
9d ago
AZN
AstraZeneca Withdraws EU Application for Lung Cancer Drug
PremiumCompany Announcements
AstraZeneca Withdraws EU Application for Lung Cancer Drug
9d ago
AstraZeneca’s Tagrisso approved in EU for certain types of NSCLC
PremiumThe FlyAstraZeneca’s Tagrisso approved in EU for certain types of NSCLC
10d ago
AZN
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
Premium
Company Announcements
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
10d ago
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
Premium
Company Announcements
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
17d ago
AstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial
PremiumThe Fly
AstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial
22d ago
AZN
MRK
AstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan
PremiumThe Fly
AstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan
24d ago
AZN
AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial
PremiumThe Fly
AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial
25d ago
AZN
AstraZeneca granted priority review for Imfinzi sBLA
PremiumThe Fly
AstraZeneca granted priority review for Imfinzi sBLA
27d ago
AZN
AstraZeneca sBLA for Imfinzi granted Priority Review in MIBC
PremiumThe FlyAstraZeneca sBLA for Imfinzi granted Priority Review in MIBC
27d ago
AZN
AstraZeneca announces FDA approval for Imfinzi
Premium
The Fly
AstraZeneca announces FDA approval for Imfinzi
28d ago
AZN
AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC
Premium
The Fly
AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC
28d ago
AZN
AstraZeneca’s Imfinzi Approved for Lung Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Imfinzi Approved for Lung Cancer Treatment
28d ago
AstraZeneca appoints Iskra Reic as Executive Vice President, International
PremiumThe Fly
AstraZeneca appoints Iskra Reic as Executive Vice President, International
29d ago
AZN
AstraZeneca Strengthens Leadership with New EVP Appointment
PremiumCompany Announcements
AstraZeneca Strengthens Leadership with New EVP Appointment
29d ago
AstraZeneca Announces Share Capital and Voting Rights
PremiumCompany Announcements
AstraZeneca Announces Share Capital and Voting Rights
1M ago
AstraZeneca announces results from CAPItello-281 trial
PremiumThe FlyAstraZeneca announces results from CAPItello-281 trial
1M ago
AZN
AstraZeneca’s Truqap combo demonstrated statistically significant improvement
Premium
The Fly
AstraZeneca’s Truqap combo demonstrated statistically significant improvement
1M ago
AZN
AstraZeneca’s Truqap Shows Promise in Prostate Cancer Trial
Premium
Company Announcements
AstraZeneca’s Truqap Shows Promise in Prostate Cancer Trial
1M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >